Cyto Ventures

Cyto Ventures is a venture capital based in Pittsburgh, founded 2018; the Altss profile covers its classification, headquarters, registration, AUM band, and...

Cyto Ventures

Cyto Ventures is a private equity firm based in Pittsburgh, US. It focuses on a Venture Capital investment approach.

Website

cyto.co

General information

Firm type

Venture Capital

Year founded

2018

Location

Region

North America

Country

United States

City

Pittsburgh

Corporate office

Pittsburgh, PA, United States

Sector focus

Digital HealthHealthcare ServicesAI/ML

What investment stages does Cyto Ventures typically target?

Cyto Ventures focuses on seed and startup-stage investments, providing the initial institutional capital to bridge academic grant funding and Series A institutional rounds. The firm backs companies at the point of laboratory-to-company translation, when scientific founders are incorporating and seeking first outside capital.

How does Cyto Ventures source its deal flow?

The firm sources opportunities through proximity to Carnegie Mellon University and the University of Pittsburgh's research ecosystems, working closely with technology transfer offices, principal investigators, and postdoctoral founders to identify commercializable intellectual property before it reaches broader venture markets. This research-proximity model gives Cyto Ventures early access to academic spinouts in biotechnology and digital health.

Which sectors does Cyto Ventures explicitly focus on?

The firm invests in biotechnology, cell and gene therapy, computational biology, precision medicine, and healthcare AI/ML applications. The unifying thread is scientist-led startups translating academic research into therapeutic platforms and digital health tools.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Aug 10, 2026. Continuous refresh with full update cycles at least every 30 days.